http://www.nephrologynow.com/publications/aspirin-in-the-primary-and-secondary-prevention-of-vascular-disease-collaborative-meta-analysis-of-individual-participant-data-from-randomised-trials Tue, 20 Jul 2010 16:54:13 -0700 http://wordpress.org/?v=2.9.2 hourly 1 http://www.nephrologynow.com/publications/aspirin-in-the-primary-and-secondary-prevention-of-vascular-disease-collaborative-meta-analysis-of-individual-participant-data-from-randomised-trials/comment-page-1#comment-98 Guest Sun, 28 Jun 2009 23:29:39 +0000 http://www.nephrologynow.com.s65750.gridserver.com/?p=905#comment-98 In the renal patients, given the significantly elevated risk of vascular events, likely important to counsel our patients about potential sequelae of vascular events vs GI bleed. I suspect with this type of informed consent, most renal patients would choose primary prophylaxis with ASA. In the renal patients, given the significantly elevated risk of vascular events, likely important to counsel our patients about potential sequelae of vascular events vs GI bleed. I suspect with this type of informed consent, most renal patients would choose primary prophylaxis with ASA.

]]>